23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › IVERIC BIO INC. › 2023-2024

IVERIC BIO INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and IVERIC BIO INC.’s Form 8-K, filed July 6, 2023 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Reported items
  • 266Asset managers, any item
  • 1,113Fund votes
  • July 6, 2023Meeting date

Results at a glance

Meeting of July 6, 2023: 3 items on IVERIC BIO INC.’s Form 8-K, filed July 6, 2023: 3 passed (calculated).

Dissent

Notable dissent: 1 other board item (26.8% against).

  • 2. The Compensation Proposal 73% of votes cast Passed (calculated) Notable · 26.8% against

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024

Explore IVERIC BIO INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by IVERIC BIO INC.

These tallies are IVERIC BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 6, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IVERIC BIO INC. — official shareholder meeting results, meeting held July 6, 2023
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
1. The Merger Proposal 109,590,29594,590458,429 --0 99.9%Passed (calculated)—
2. The Compensation Proposal 79,668,09729,241,9611,233,256 --0 73%Passed (calculated)—
3. The Adjournment Proposal 101,361,1848,291,820490,310 --0 92%Passed (calculated)—

Source: IVERIC BIO INC., Form 8-K, filed with the SEC on July 6, 2023 — read the filing on EDGAR.

How asset managers voted at the IVERIC BIO INC. 2023-2024 meeting

266 asset managers disclosed a vote on at least one IVERIC BIO INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IVERIC BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc…

No official matchEXTRAORDINARY TRANSACTIONS

Combines 4 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 91 asset managers

Description as filed by funds: To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc. ("IVERIC"), Astellas US Holding, Inc. ("Parent"), Berry Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc., pursuant to which Merger Sub will merge with and into IVERIC, and IVERIC will become a wholly owned subsidiary of Parent (the "Merger").

The 91 asset managers below reported 42,485,811 for, 450,000 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 42,485,811ABSTAIN: 450,000
Largest asset managers voting on “To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated April 28, 2023, by and among IVERIC ” at IVERIC BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,237,2710 00For
BlackRock5,736,7910 00For
Investment Managers Series Trust II3,661,7470 00For
State Street2,778,3670 00For
Fidelity2,621,3220 00For
Invesco2,010,0480 00For
MERGER FUND1,302,9080 00For
TIAA1,027,2490 00For
Dimensional1,003,2010 00For
JANUS INVESTMENT FUND999,0580 00For
Charles Schwab981,7480 00For
AllianceBernstein555,2220 00For
Federated Hermes00 450,0000Abstain
Equitable447,5340 00For
American Century421,3890 00For
FRANKLIN STRATEGIC SERIES383,6000 00For
Principal336,9890 00For
FINANCIAL INVESTORS TRUST315,6360 00For
TimesSquare Capital Management, LLC263,4000 00For
QUANTITATIVE MASTER SERIES LLC232,6920 00For
Columbia Threadneedle232,0940 00For
Direxion Shares ETF Trust227,1110 00For
Jackson National226,5990 00For
Putnam203,3410 00For
ARBITRAGE FUNDS180,0320 00For

Showing the 25 largest of 91 asset managers. All 91 are in the interactive database (link above).

To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit…

No official matchCORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

86% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting.

The 89 asset managers below reported 34,238,639 for, 5,453,627 against, 20,487 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 34,238,639AGAINST: 5,453,627ABSTAIN: 20,487
Largest asset managers voting on “To approve the adjournment of the special meeting to a later date or dates if necessary or appropriate to soli” at IVERIC BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,237,2710 00For
BlackRock5,736,7910 00For
State Street02,778,367 00Against
Fidelity99,4362,521,886 00Against
Invesco2,010,0480 00For
MERGER FUND1,302,9080 00For
TIAA1,027,2490 00For
Dimensional1,003,2010 00For
JANUS INVESTMENT FUND999,0580 00For
Charles Schwab981,7480 00For
Investment Managers Series Trust II569,8420 00For
AllianceBernstein555,2220 00For
Federated Hermes450,0000 00For
Equitable447,5340 00For
American Century421,3890 00For
FRANKLIN STRATEGIC SERIES383,6000 00For
Principal336,9890 00For
FINANCIAL INVESTORS TRUST315,6360 00For
TimesSquare Capital Management, LLC263,4000 00For
QUANTITATIVE MASTER SERIES LLC232,6920 00For
Columbia Threadneedle232,0940 00For
Direxion Shares ETF Trust227,1110 00For
Jackson National226,5990 00For
Putnam203,3410 00For
ARBITRAGE FUNDS180,0320 00For

Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).

To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 8 wordings of this item as funds reported it.

68% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 257 asset managers

Description as filed by funds: To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 88 asset managers voting on “To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its na” at IVERIC BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard013,237,271 00Against
BlackRock5,736,7910 00For
State Street2,778,3670 00For
Fidelity2,610,75010,572 00For
Invesco2,010,0480 00For
MERGER FUND1,302,9080 00For
TIAA01,027,249 00Against
Dimensional01,003,201 00Against
JANUS INVESTMENT FUND999,0580 00For
Charles Schwab0981,748 00Against
Investment Managers Series Trust II559,74210,100 00For
AllianceBernstein0555,222 00Against
Federated Hermes00 450,0000Abstain
Equitable236,810210,724 00Mixed
American Century421,3890 00For
FRANKLIN STRATEGIC SERIES0383,600 00Against
Principal241,35895,631 00Mixed
FINANCIAL INVESTORS TRUST315,6360 00For
QUANTITATIVE MASTER SERIES LLC232,6920 00For
Columbia Threadneedle232,0940 00For
Direxion Shares ETF Trust227,1110 00For
Jackson National203,63622,963 00Mixed
Putnam0203,341 00Against
ARBITRAGE FUNDS180,0320 00For
Lincoln Financial163,92012,000 00Mixed

Fund voting reports, all 88 managers: 20,512,188 for, 18,367,910 against, 569,255 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 190 asset managers voting on “To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its na” at IVERIC BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Avoro Capital Advisors LLC8,500,0000 00For
Man Group plc07,068,940 00Against
State Street5,188,6680 00For
BlackRock3,786,34251,108 00For
UBS2,893,531344,120 00Mixed
FARALLON CAPITAL MANAGEMENT LLC3,134,7990 00For
GEODE CAPITAL MANAGEMENT, LLC2,620,6320 00For
TIG Advisors, LLC2,167,8860 00For
Segantii Capital Management Ltd2,085,0000 00For
AllianceBernstein02,034,996 00Against
Invesco2,006,7080 00For
Meeder Advisory Services, Inc.2,000,0000 00For
BRAIDWELL LP1,802,7990 00For
BALYASNY ASSET MANAGEMENT L.P.01,583,715 00Against
Deep Track Capital, LP1,231,8260 00For
MPM BioImpact LLC1,214,6620 00For
Nuveen1,6471,191,930 00Against
Soleus Capital Management, L.P.1,140,9430 14,1000For
KINGDON CAPITAL MANAGEMENT, L.L.C.01,153,000 00Against
Redmile Group, LLC01,111,111 00Against
Sand Grove Capital Management LLP1,088,0940 00For
Charles Schwab0997,771 00Against
Magnetar Financial LLC943,7560 00For
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)832,1130 00For
ARMISTICE CAPITAL, LLC825,3060 00For

Institutional-manager reports, all 190 managers: 58,567,158 for, 19,043,139 against, 665,790 abstained, 600 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Advisory Vote on Golden Parachutes

No official matchSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

89% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 1,451,365 for, 182,622 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 1,451,365AGAINST: 182,622
Largest asset managers voting on “Advisory Vote on Golden Parachutes” at IVERIC BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.1,450,0000 00For
JPMorgan0182,622 00Against
Desjardins Global Asset Management Inc.1,3650 00For
Taconic Capital Advisors LP00 00--

Largest IVERIC BIO INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 137,249,579 shares outstanding at the time of that meeting.

Fund voting reports: top IVERIC BIO INC. shareholders by shares voted on “To approve, by non-binding, advisory vote, compensation that may be paid or become payable by…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.64%
2BlackRock 4.18%
3State Street 2.02%
4Fidelity 1.91%
5Invesco 1.46%
6MERGER FUND 0.95%
7TIAA 0.75%
8Dimensional 0.73%
9JANUS INVESTMENT FUND 0.73%
10Charles Schwab 0.72%
Institutional-manager reports: top IVERIC BIO INC. shareholders by shares voted on “To approve, by non-binding, advisory vote, compensation that may be paid or become payable by…”, 2023-2024
#Asset manager % of shares outstanding
1Avoro Capital Advisors LLC 6.19%
2Man Group plc 5.15%
3State Street 3.78%
4BlackRock 2.80%
5UBS 2.36%
6FARALLON CAPITAL MANAGEMENT LLC 2.28%
7GEODE CAPITAL MANAGEMENT, LLC 1.91%
8TIG Advisors, LLC 1.58%
9Segantii Capital Management Ltd 1.52%
10AllianceBernstein 1.48%

Reported IVERIC BIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

IVERIC BIO INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Norges Bank268,586 0.20%Form 13F, quarter ended March 31, 2024

Percentages above are of 137,249,579 shares outstanding, as reported by IVERIC BIO INC. on its Form 10-Q dated March 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At IVERIC BIO INC.'s shareholder meeting held July 6, 2023, in the 2023-2024 proxy season, 266 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,113 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IVERIC BIO INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding, advisory vote, compensation that may be paid or become payable by… — the reporting funds and managers cast 68% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IVERIC BIO INC.’s 10-Q dated March 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

IVERIC BIO INC. proxy season coverage: 2023-2024 (this page).

Cite this page

Proxy Votes Now, “IVERIC BIO INC. 2023 Special Meeting (2023-2024 season): Vote Results”, https://proxyvotesnow.com/company/iveric-bio-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.